As observed, the presence of other associated diseases in addition to coinfection can worsen the clinical situation of these patients, who are in advanced immunodeficiency, since at the beginning of treatment, 70.9% of the patients had a CD4 T lymphocyte count below 200 cells/mm3 [15]. This evidence concerns the gene CD4 and immunodeficiency disease.